Navigation Links
Argos Therapeutics Presents Immunosuppression Data for Soluble CD83,at the American Society of Transplantation Congress 2007

DURHAM, N.C.--(BUSINESS WIRE)--May 4, 2007 - Argos Therapeutics today announced the presentation of data on the immunosuppressive properties of soluble CD83 at the 7th Joint American Transplant meeting to be held in San Francisco, May 5-9. The presentations will be made in collaboration with scientists at the University of Western Ontario.

"These data suggest that soluble CD83 is able to extend graft survival in transplantation, and that it can also act synergistically with other immunosuppressive agents," commented Dr. Stephen Brand, Director of Biotherapeutics at Argos Therapeutics. "sCD83 appears to be able to maintain antigen presenting cells in an immature state, and these immunologically tolerant cells favor regulatory T-cell generation because they are less effective in activating naive T and B cells."

"This emerging activity profile for sCD83, as well as its ability to suppress antibody production without systemic suppression, may provide advantages over currently available B-cell targeting therapies," said Dr. Charles Nicolette, Chief Scientific Officer and Vice President of Research and Development of Argos. "The extended graft survival that we have observed thus far indicates that sCD83 could potentially provide enhanced organ function, without immune rejection, and may serve to reduce the toxic profile associated with many commonly used immunotherapeutic agents. These data support Argos' plans to conduct additional studies with CD83 in transplantation and autoimmune models, which will provide important information as we develop a clinical strategy for this candidate."

Data will be discussed in the following presentations:

-- Abstract # 1697: "Soluble CD83 in combination with Rapamycin and anti-CD45RB monoclonal antibody induces long-term graft survival in a mouse cardiac transplantation model"

-- Abstract #116: "Soluble CD83 can inhibit B-cell activation and differentiati
'"/>




Page: 1 2

Related medicine technology :

1. Cell Therapeutics, Inc. Management to Discuss Todays Announcement of Interim Pixantrone Study Results
2. Halozyme Therapeutics Enhanze Technology Large Protein Molecule Therapeutic Clinical Trial Results Presented at the 34th Annual Meeting of the Controlled Release Society
3. CV Therapeutics Identifies Potential Anti-Diabetic Mechanism of Action for Ranexa
4. Fat Kills Cancer: Turning Stem Cells from Fat Tissue into Personalized, Cancer-Targeted Therapeutics
5. A 4-Week Therapy with Transition Therapeutics E1-I.N.T. Leads to Sustained Reductions in Blood Glucose Levels for 6 Months Post-treatment in Type 2 Diabetes Patients
6. Clinical Trial Suggests Bone Marrow Stem Cells Are Useful for Spinal Cord Injury; PrimeCell Therapeutics Provided Pre-Clinical Study
7. Opexa Therapeutics Reports Positive Top-line Data in Phase I/II Extension Trial with Tovaxin for Multiple Sclerosis
8. Orexigen Therapeutics to Present Data on Contrave Impact on Visceral Fat and Insulin Resistance at American Diabetes Association 67th Scientific Sessions in Chicago June 23
9. Allos Therapeutics Reports Results for Phase 3 Enrich Study of Efaproxyn in Women With Brain Metastases Originating From Breast Cancer
10. Trophos Publishes ALS Article in Journal of Pharmacology and Experimental Therapeutics
11. Novelos Therapeutics Announces Encouraging Results in Ongoing Phase 2 Ovarian Cancer Trial at Dana-Farber/Partners Cancer Care
Post Your Comments:
(Date:8/27/2014)... IRIDEX Corporation (NASDAQ: IRIX ) today ... is scheduled to make an investor presentation at the Robert ... Time on Wednesday, September 3, in New York City.  ... will be available in the Investors section of the IRIDEX ... IRIDEX Corporation was founded in 1989 and is ...
(Date:8/27/2014)... , Aug. 27, 2014   Auxilium Pharmaceuticals , Inc. ... biopharmaceutical company, today announced that certain members of the ... Healthcare Conference to be held September 8-10, 2014 in ... , Chief Executive Officer and President, is scheduled to ... portfolio at 10:55 a.m. ET on Wednesday, September 10, ...
(Date:8/27/2014)... PARK, Calif. , Aug. 27, 2014 ... the U.S. Food and Drug Administration (FDA) to initiate ... in patients with complete cervical spinal cord injury.  The ... 1 clinical study of the product, and is designed ... AST-OPC1 in patients with complete cervical spinal cord injuries, ...
Breaking Medicine Technology:Auxilium Pharmaceuticals, Inc. To Present At The Morgan Stanley Healthcare Conference 2Auxilium Pharmaceuticals, Inc. To Present At The Morgan Stanley Healthcare Conference 3Asterias Biotherapeutics Receives U.S. FDA Clearance to Initiate Phase 1/2a Clinical Trial of AST-OPC1 in Patients with Cervical Complete Spinal Cord Injury 2Asterias Biotherapeutics Receives U.S. FDA Clearance to Initiate Phase 1/2a Clinical Trial of AST-OPC1 in Patients with Cervical Complete Spinal Cord Injury 3Asterias Biotherapeutics Receives U.S. FDA Clearance to Initiate Phase 1/2a Clinical Trial of AST-OPC1 in Patients with Cervical Complete Spinal Cord Injury 4Asterias Biotherapeutics Receives U.S. FDA Clearance to Initiate Phase 1/2a Clinical Trial of AST-OPC1 in Patients with Cervical Complete Spinal Cord Injury 5
... Upsher-Smith Laboratories, Inc., of Maple Grove, Minnesota is ... Sodium, USP, 3 mg Tablets to include additional products ... May 17, 2010 and November 17, 2010.  The company ... a single bottle labeled as Jantoven® Warfarin Sodium, USP, ...
... Feb. 18, 2011 PreXion, Inc., ( www.prexion.com ... Beam Computed Tomography (CBCT) Imaging systems for dentistry, ... shipping a new 3D cone beam imaging product, ... new system incorporates PreXion,s proprietary CLEARimage™ technology that ...
Cached Medicine Technology:Upsher-Smith Laboratories Announces Expansion of Voluntary Nationwide Recall 2Upsher-Smith Laboratories Announces Expansion of Voluntary Nationwide Recall 3PreXion Launches New Faster, Lower Radiation PreXion3D Elite Cone Beam Imaging System 2PreXion Launches New Faster, Lower Radiation PreXion3D Elite Cone Beam Imaging System 3
(Date:8/27/2014)... Aspirus Wausau Hospital today announced the first ... Digital O.R. at Aspirus Wausau Hospital, in Wausau, WI. ... rooms will be Buzz, a centralized surgical hub for ... planning, navigation, imaging and communications connectivity. , Buzz ... and hardware all controlled from the full HD 42” ...
(Date:8/27/2014)... SCOTT Sports is excited to announce ... mountain bike and BMX park. SCOTT will provide Wasatch ... adult and youth sizes for the park’s rental bike program. ... in Ogden, Utah, recently moved its U.S. headquarters from Sun ... to be a partner with the Wasatch Bike Park, what ...
(Date:8/27/2014)... HealthDay Reporter TUESDAY, Aug. ... the need for blood transfusions might also protect the brains ... (EPO), which stimulates red blood cell production, appears to prevent ... researcher Dr. Petra Huppi, a professor of pediatrics and newborn ... real test of whether EPO protects the brains of these ...
(Date:8/27/2014)... Centre into Microtechnologies, is coordinating the microSCALE ... based on microtechnologies to tackle the problems ... among others. IK4-Ikerlan, Ceit-IK4, IK4-Tekniker, the Mondragon ... microGUNE on this project, which is being ... programme of the Government of the Basque ...
(Date:8/27/2014)... water and oil and are persistent towards aggressive ... characteristics have made the fluorochemicals useful in numerous ... paper and board. , The problem with fluorochemicals ... and accumulate in both humans and the environment. ... effects, such as cancer, increased cholesterol and a ...
Breaking Medicine News(10 mins):Health News:Aspirus Wausau Hospital Announces First Large Scale Digital Operating Room Integration Project in the US 2Health News:Aspirus Wausau Hospital Announces First Large Scale Digital Operating Room Integration Project in the US 3Health News:SCOTT Sports to Sponsor Wasatch Indoor Bike Park 2Health News:Hormone Might Help Preemies' Brains 2Health News:Hormone Might Help Preemies' Brains 3Health News:Microtechnologies for driving forward mobility and human health 2Health News:Leading scientists call for a stop to non-essential use of fluorochemicals 2Health News:Leading scientists call for a stop to non-essential use of fluorochemicals 3
... violence often accompanied by attempts to get young women pregnant ... says that male partners of teenage girls and young women ... to sabotage the birth control the women are using. , ... Contraception , also finds that women who experience both ...
... , PITTSBURGH , Jan. 25 ... for serious athletes, and now the company is throwing its brand ... who know how to push the limits:  Dick,s Sporting Goods ... and energy products and other nutritional supplements is now the presenting ...
... ... ... (FEIN #,s 84-1402*** & 80-0510***, CO Charity #20093014664) is calling on all Cannabis Churches ... issues. "Shamans, Doctors, and Spiritual Leaders have been in charge of healing all the worlds ...
... ... of leading B2B online comparison shopping marketplaces, today announced that it now has the ... can now streamline medical supply procurement by using the www.med32.com multivendor comparison-shopping ... ...
... Young women and teenage girls often face efforts ... pregnancy including damaging condoms and destroying contraceptives ... associated with physical or sexual violence, a study by ... found. Published online today in the January issue ...
... , ... Rehabiltation Services for children (BHRS/Wraparound) offered from the Christian perspective, promote faith-formation. , ... (PRWEB) January 24, 2010 ... teamed up with Parakleseos, LLC, a Christian-based behavioral health practice in Beaver, PA in ...
Cached Medicine News:Health News:Male Abusers Often Sabotage Birth Control With Partners 2Health News:GNC Becomes a Presenting Sponsor for the Pittsburgh Health & Fitness Expo of the Dick's Sporting Goods Pittsburgh Marathon 2Health News:GNC Becomes a Presenting Sponsor for the Pittsburgh Health & Fitness Expo of the Dick's Sporting Goods Pittsburgh Marathon 3Health News:Greenfaith Ministry Calls on Churches & Doctors, to Address all Cannabis Issues and Regulation 2Health News:Greenfaith Ministry Calls on Churches & Doctors, to Address all Cannabis Issues and Regulation 3Health News:Greenfaith Ministry Calls on Churches & Doctors, to Address all Cannabis Issues and Regulation 4Health News:Online Medical Supply Comparison Shopping Service Saves Nursing Homes Money 2Health News:Reproductive coercion often is accompanied by physical or sexual violence, study finds 2Health News:Reproductive coercion often is accompanied by physical or sexual violence, study finds 3Health News:Christian Nonprofit and Behavioral Health Practice Team Up to Help Children 2
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
Medicine Products: